Marybeth Camboni

565 total citations
14 papers, 478 citations indexed

About

Marybeth Camboni is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Marybeth Camboni has authored 14 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Physiology. Recurrent topics in Marybeth Camboni's work include Muscle Physiology and Disorders (9 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Marybeth Camboni is often cited by papers focused on Muscle Physiology and Disorders (9 papers), Virus-based gene therapy research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Marybeth Camboni collaborates with scholars based in United States. Marybeth Camboni's co-authors include Paul T. Martin, Rui Xu, Kumaran Chandrasekharan, Jung Hae Yoon, Paul M.L. Janssen, Ajit Varki, Ying Xu, Chrystal L. Montgomery, Zarife Sahenk and Louis G. Chicoine and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Science Translational Medicine.

In The Last Decade

Marybeth Camboni

14 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marybeth Camboni United States 11 406 166 102 95 67 14 478
Kristin N. Heller United States 14 569 1.4× 180 1.1× 137 1.3× 74 0.8× 80 1.2× 20 644
Ludovic Arandel France 9 351 0.9× 96 0.6× 69 0.7× 62 0.7× 70 1.0× 11 393
Carmen Bertoni United States 17 662 1.6× 246 1.5× 51 0.5× 86 0.9× 39 0.6× 27 763
Evelyne Gicquel France 11 379 0.9× 134 0.8× 115 1.1× 35 0.4× 89 1.3× 17 466
Kumaran Chandrasekharan United States 14 286 0.7× 77 0.5× 209 2.0× 59 0.6× 47 0.7× 17 488
Fatima Amor France 9 430 1.1× 75 0.5× 49 0.5× 51 0.5× 38 0.6× 10 474
T G Sherratt United Kingdom 8 373 0.9× 94 0.6× 98 1.0× 55 0.6× 46 0.7× 10 422
Joël Rousseau Canada 19 810 2.0× 235 1.4× 69 0.7× 69 0.7× 69 1.0× 31 910
J.E. Morgan United Kingdom 6 324 0.8× 96 0.6× 52 0.5× 42 0.4× 24 0.4× 17 388
Charis L. Himeda United States 19 894 2.2× 318 1.9× 186 1.8× 46 0.5× 47 0.7× 25 995

Countries citing papers authored by Marybeth Camboni

Since Specialization
Citations

This map shows the geographic impact of Marybeth Camboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marybeth Camboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marybeth Camboni more than expected).

Fields of papers citing papers by Marybeth Camboni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marybeth Camboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marybeth Camboni. The network helps show where Marybeth Camboni may publish in the future.

Co-authorship network of co-authors of Marybeth Camboni

This figure shows the co-authorship network connecting the top 25 collaborators of Marybeth Camboni. A scholar is included among the top collaborators of Marybeth Camboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marybeth Camboni. Marybeth Camboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Velazquez, Victoria M., et al.. (2017). Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting. Molecular Therapy — Methods & Clinical Development. 4. 159–168. 36 indexed citations
2.
Fu, Haiyan, et al.. (2016). Functional benefits of systemic rAAV9-hids gene delivery in MPS II mouse model. Molecular Genetics and Metabolism. 117(2). S47–S47. 1 indexed citations
3.
Meadows, Aaron S., F. Jason Duncan, Marybeth Camboni, et al.. (2015). A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB. PubMed. 26(4). 228–242. 20 indexed citations
4.
Martin, Paul T., Marybeth Camboni, Kumaran Chandrasekharan, et al.. (2014). A Comparative Study of N-glycolylneuraminic Acid (Neu5Gc) and Cytotoxic T Cell (CT) Carbohydrate Expression in Normal and Dystrophin-Deficient Dog and Human Skeletal Muscle. PLoS ONE. 9(2). e88226–e88226. 14 indexed citations
5.
Martin, Paul T., Marybeth Camboni, Rui Xu, et al.. (2013). N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice. Glycobiology. 23(7). 833–843. 14 indexed citations
6.
Camboni, Marybeth, Carlos J. Miranda, Jung Hae Yoon, et al.. (2013). Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease. Neurobiology of Disease. 62. 31–43. 5 indexed citations
7.
Chicoine, Louis G., Louise R. Rodino‐Klapac, Guohong Shao, et al.. (2013). Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates. Molecular Therapy. 22(4). 713–724. 64 indexed citations
8.
Camboni, Marybeth, et al.. (2011). Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53‐deficient mice. The Journal of Pathology. 226(1). 40–49. 19 indexed citations
9.
10.
Chandrasekharan, Kumaran, Jung Hae Yoon, Ying Xu, et al.. (2010). A Human-Specific Deletion in Mouse Cmah Increases Disease Severity in the mdx Model of Duchenne Muscular Dystrophy. Science Translational Medicine. 2(42). 42ra54–42ra54. 86 indexed citations
11.
Camboni, Marybeth, et al.. (2009). Overexpression of Galgt2 Reduces Dystrophic Pathology in the Skeletal Muscles of Alpha Sarcoglycan-Deficient Mice. American Journal Of Pathology. 175(1). 235–247. 42 indexed citations
12.
Martin, Paul T., Rui Xu, Louise R. Rodino‐Klapac, et al.. (2008). Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice. American Journal of Physiology-Cell Physiology. 296(3). C476–C488. 73 indexed citations
13.
14.
Xu, Rui, Kumaran Chandrasekharan, Jung Hae Yoon, Marybeth Camboni, & Paul T. Martin. (2007). Overexpression of the Cytotoxic T Cell (CT) Carbohydrate Inhibits Muscular Dystrophy in the dyW Mouse Model of Congenital Muscular Dystrophy 1A. American Journal Of Pathology. 171(1). 181–199. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristin N. Heller Breakdown of academic impact, for papers by Ludovic Arandel Breakdown of academic impact, for papers by Carmen Bertoni Breakdown of academic impact, for papers by Evelyne Gicquel Breakdown of academic impact, for papers by Kumaran Chandrasekharan Breakdown of academic impact, for papers by Fatima Amor Breakdown of academic impact, for papers by T G Sherratt Breakdown of academic impact, for papers by Joël Rousseau Breakdown of academic impact, for papers by J.E. Morgan Breakdown of academic impact, for papers by Charis L. Himeda
Rankless by CCL
2026